EU approves German state aid for Sanofi insulin plant
SNY•The European Commission approved German public support for Sanofi’s new Frankfurt insulin plant in September 2026. Construction began October 19, with full insulin active ingredient production planned for 2032, subject to licensing.
1. Plant construction begins
The European Commission approved public support from Germany’s federal government, the state of Hesse and the city of Frankfurt for Sanofi’s new insulin plant. Construction began October 19, and full insulin active ingredient production is planned for 2032, subject to licensing.
